Vanguard Group Inc. Lowers Stock Holdings in Revvity Inc. $RVTY

Vanguard Group Inc. cut its holdings in Revvity Inc. (NYSE:RVTY) by 4.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 13,518,061 shares of the company’s stock after selling 570,737 shares during the period. Vanguard Group Inc. owned 11.65% of Revvity worth $1,184,858,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in RVTY. CYBER HORNET ETFs LLC acquired a new position in Revvity in the second quarter valued at $32,000. MUFG Securities EMEA plc acquired a new stake in Revvity in the 2nd quarter worth about $34,000. CVA Family Office LLC grew its holdings in Revvity by 79.0% in the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company’s stock valued at $40,000 after buying an additional 181 shares during the period. Headlands Technologies LLC purchased a new stake in Revvity in the 2nd quarter valued at about $49,000. Finally, Smartleaf Asset Management LLC increased its stake in shares of Revvity by 56.8% during the 3rd quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock valued at $58,000 after acquiring an additional 250 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Price Performance

Revvity stock opened at $100.37 on Friday. The firm has a fifty day moving average of $103.21 and a 200-day moving average of $96.07. Revvity Inc. has a 52-week low of $81.36 and a 52-week high of $120.39. The company has a quick ratio of 1.40, a current ratio of 1.68 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $11.38 billion, a P/E ratio of 48.25, a PEG ratio of 2.13 and a beta of 1.07.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.15. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The firm had revenue of $772.06 million during the quarter, compared to analysts’ expectations of $759.81 million. During the same period in the prior year, the company earned $1.42 EPS. The firm’s revenue was up 5.9% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. As a group, analysts predict that Revvity Inc. will post 4.94 EPS for the current year.

Revvity announced that its board has initiated a share repurchase plan on Monday, October 27th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 8.7% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Friday, April 17th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s payout ratio is 13.46%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on RVTY shares. Evercore raised their target price on shares of Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 3rd. Barclays lifted their price target on shares of Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Tuesday, February 3rd. Weiss Ratings reissued a “sell (d)” rating on shares of Revvity in a research note on Monday, December 29th. JPMorgan Chase & Co. increased their target price on Revvity from $100.00 to $105.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 3rd. Finally, The Goldman Sachs Group initiated coverage on Revvity in a report on Tuesday, December 9th. They issued a “neutral” rating and a $105.00 target price on the stock. Five analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $113.67.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.